Dudediligence.

Clene Inc

CLNNNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$87,000Sep ’24$91,000Dec ’24$81,000Mar ’25$27,000Jun ’25$15,000Sep ’25$77,000Dec ’25$15,000Mar ’26$90,000Jun ’26
Net income, by quarter
−$8.0MSep ’24−$13.5MDec ’24−$751,000Mar ’25−$7.4MJun ’25−$8.8MSep ’25−$9.2MDec ’25−$8.1MMar ’26−$13.4MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$723,000$473,000$654,000$342,000$200,000
Gross profit$434,000$447,000$533,000$272,000$157,000
Operating income−$50.0M−$48.4M−$40.5M−$33.1M−$23.1M
Net income−$9.7M−$29.9M−$49.5M−$39.4M−$26.2M
Operating cash flow−$34.6M−$39.0M−$30.2M−$21.3M−$18.5M
Free cash flow−$36.0M−$44.2M−$30.5M−$21.3M−$18.6M
Cash$50.3M$18.3M$28.8M$12.2M$5.2M
Debtnone on filenone on filenone on filenone on file$17.8M
Shares outstanding62.3M74.8M6.4M8.1M10.8M